Medical Services to Continue Experimental Use of VScan TB Test Kit

September 13, 2004
EDMONTON, Canada, Sept. 13, 2004 -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that the experimental use of its VScan TB test kit has been extended in Chinese hospitals. The hospitals currently using the VScan TB test kit have received regulatory approval to continue to use the VScan TB test kit on an experimental basis while applying for regulatory approval. Additional hospitals will also begin using the TB test kits.

Based on the excellent test results that have been obtained in PRC hospitals using the VScan TB test kit, particularly the fact that the VScan TB test kits do not give false positives, regulatory authorities have given permission for the hospitals to continue using the VScan TB test kit on an experimental basis in PRC hospitals. The data being generated by the hospitals will ultimately be submitted to the SDA to help set testing standards for Tuberculosis (TB) in China. There is no other rapid test kit available that measures only live TB and does not give false positives.

Tuberculosis kills more people each year than all of the other infectious diseases combined. Testing for TB has become mandatory when related to immigration in most countries. Tuberculosis will kill over 8 million people this year. As the test results of the VScan TB test kits become published it is expected that the demand for the kit will be very high and it is reasonable to expect that the company will sell in excess of 4 to 5 million TB test kits per year.

 About VScan

The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1& 2 subgroup O, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile. The kits cannot be sold in Canada.